Taiwan has antimalarial drug seen as possible COVID-19 treatment: CECC
03/26/2020 10:44 PM
Quinoline antimalarial drugs, which have recently been discussed as a possible treatment for the COVID-19 coronavirus, are produced in Taiwan and could be made available if testing proves them to be effective, the Central Epidemic Command Center (CECC) said Thursday.
(Full text of the story is now in CNA English news archive. To view the full story, you will need to be a subscribed member of the CNA archive. To subscribe, please read here.)
Latest
- Business
Taiwan stock market outperforms Japan, South Korea: Central bank
12/27/2025 02:51 PM - Business
EVA Air to spend up to US$1.94 billion to add new Boeing aircraft
12/27/2025 12:41 PM - Cross-Strait
Taipei deputy mayor leads delegation to Shanghai for city-level summit
12/27/2025 12:30 PM - Society
Taiwan's highest mountains get snow
12/27/2025 12:01 PM - Society
Taiwan headline news
12/27/2025 11:41 AM